| This article has been cited by |
| 1 | Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients | |
| Matilde Iorizzo,Michela Starace,Sergio Vano-Galvan,Bianca Maria Piraccini,Pascal Reygagne,Lidia Rudnicka,Tatiana Silyuk,Rodney Sinclair,Antonella Tosti |
| Journal of the American Academy of Dermatology.2022;87(3)666 |
| [DOI] |
|
| 2 | Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life | |
| Donald E. Greydanus,Roua Azmeh,Maria Demma Cabral,Cheryl A. Dickson,Dilip R. Patel |
| Disease-a-Month.2021;67(4)101103 |
| [DOI] |
|
| 3 | Refractory folliculitis decalvans treated with biologics: Case series in 4 situations | |
| Alejandro Lobato-Berezo,Ramon M. Pujol |
| Dermatologic Therapy.2022;35(10)101103 |
| [DOI] |
|
| 4 | Refractory folliculitis decalvans treated with biologics: Case series in 4 situations | |
| Trent Walker,Catherine Grace Hobayan,Suchita Sampath,Shannon C. Trotter |
| Dermatologic Therapy.2022;35(10)85 |
| [DOI] |
|
| 5 | Dermatoses inflammatoires et auto-immunes | |
| C. Lenormand,N. Kluger,C. Velter |
| Annales de Dermatologie et de Vénéréologie - FMC.2022;2(2)2/2S3 |
| [DOI] |
|
| 6 | Therapy-refractory folliculitis decalvans treated with certolizumab pegol | |
| Matthias Hoy,Markus Böhm |
| International Journal of Dermatology.2022;61(1)2/2S3 |
| [DOI] |
|
